P
DXCM icon

&Partners’s DexCom DXCM Stock Holding History

&Partners’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.51M Buy
22,294
+1,218
+6% +$81.1K 0.01% 1183
2026
Q1 		$1.32M Buy
21,076
+6,598
+46% +$459K 0.01% 1146
2025
Q4 		$951K Sell
14,478
-7,421
-34% -$480K 0.01% 1245
2025
Q3 		$1.46M Buy
21,899
+149
+0.7% +$11.8K 0.01% 908
2025
Q2 		$1.88M Sell
21,750
-1,170
-5% -$91.7K 0.01% 698
2025
Q1 		$1.56M Buy
22,920
+8,142
+55% +$664K 0.02% 638
2024
Q4 		$1.2M Buy
14,778
+2,859
+24% +$212K 0.01% 692
2024
Q3 		$797K Buy
11,919
+2,402
+25% +$197K 0.02% 658
2024
Q2 		$1.08M Buy
+9,517
New +$1.2M 0.05% 328

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

&Partners's DXCM Position: Q2 2026 in Review

&Partners increased its DexCom (DXCM) stake by 5.8% in Q2 2026, buying an estimated $81.1K and bringing the position to 22,294 shares worth $1.51M. The position accounts for 0.01% of the portfolio, ranked #1183.

&Partners first reported a position in DXCM in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.88M in Q2 2025. 973 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • &Partners held 22,294 shares of DexCom worth $1.51M as of Q2 2026.
  • &Partners bought 1,218 DexCom shares in Q2 2026, an estimated $81.1K.
  • DexCom made up 0.01% of &Partners's portfolio in Q2 2026, its #1183 holding.
  • &Partners first reported a position in DexCom in Q2 2024 and has held it in 9 quarters since.
  • &Partners's DexCom position peaked at $1.88M in Q2 2025.
  • 973 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.